NCT02914145View on ClinicalTrials.gov

Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique

NACompletedINTERVENTIONAL
Enrollment

240,502

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Malaria
Interventions
DRUG

Dihydroartemisinin-piperaquine

Mass drug administration

All Listed Sponsors
collaborator

Barcelona Institute for Global Health

OTHER

lead

Centro de Investigacao em Saude de Manhica

OTHER

NCT02914145 - Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique | Biotech Hunter | Biotech Hunter